Diantha Duvall, CHIEF FINANCIAL OFFICER at GENOCEA BIOSCIENCES, INC. (GNCA), sold 1,355 shares at $0.06 ($81) on 2022-06-02, disclosed to the SEC on 2022-06-03.
Open-market sale of $81 GNCA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNCA | SELL | 2022-03-17 | $3K | — | Filing → |
| BIVV | SELL | 2017-06-29 | $49K | — | Filing → |